The Washington State Prescription Drug Affordability Board's selection of drugs for affordability review.
- DOI
- 10.18553/jmcp.2026.32.7.847
- Published
- 2026 Jul
- Container
- Journal of managed care & specialty pharmacy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.18553/jmcp.2026.32.7.847,
title = {The Washington State Prescription Drug Affordability Board's selection of drugs for affordability review.},
author = {Barthold D and Pistoresi R and Kawaguchi-Suzuki M and Xing J and Borumand S and Truong H and Gipson G and Neuenschwander M},
year = {2026},
journal = {Journal of managed care \& specialty pharmacy},
doi = {10.18553/jmcp.2026.32.7.847},
url = {https://doi.org/10.18553/jmcp.2026.32.7.847}
}RIS
TY - JOUR TI - The Washington State Prescription Drug Affordability Board's selection of drugs for affordability review. AU - Barthold D AU - Pistoresi R AU - Kawaguchi-Suzuki M AU - Xing J AU - Borumand S AU - Truong H AU - Gipson G AU - Neuenschwander M PY - 2026 JO - Journal of managed care & specialty pharmacy DO - 10.18553/jmcp.2026.32.7.847 UR - https://doi.org/10.18553/jmcp.2026.32.7.847 ER -
APA
D, B., R, P., M, K., J, X., S, B., H, T., G, G., & M, N. (2026). The Washington State Prescription Drug Affordability Board's selection of drugs for affordability review.. Journal of managed care & specialty pharmacy. https://doi.org/10.18553/jmcp.2026.32.7.847
Source records
- pubmed · retrieved 2026-09-26T22:39:58.503Z